0:00:00 | the present you data for the treatment of the rack out this function and give |
---|
0:00:05 | an overview of this article |
---|
0:00:08 | you're right account this function is often perceived by locations and sexual partners as a |
---|
0:00:14 | serious problem that can jeopardise quality of life |
---|
0:00:18 | psychosocial |
---|
0:00:19 | or emotional will be |
---|
0:00:21 | and the partnership in the long term |
---|
0:00:25 | although many treatment modalities have been introduced to address it |
---|
0:00:29 | the end of pde five inhibitors have revolutionised the medical treatment for e d which |
---|
0:00:36 | offer advantages over other treatment modalities in terms of use of administration and costs |
---|
0:00:43 | to date there are four pde five inhibitors |
---|
0:00:47 | so but also |
---|
0:00:49 | fire data fell how to fill and a part of the l approved for the |
---|
0:00:54 | treatment of direct of this function well why |
---|
0:00:57 | and you've done to fill has been approved thirteen countries |
---|
0:01:01 | including career |
---|
0:01:04 | in this review |
---|
0:01:05 | we highlight the evidences for the efficacy and safety you gender fill in the treatment |
---|
0:01:11 | of d |
---|
0:01:15 | you don't have l one of selective pde five inhibitors was developed in korea and |
---|
0:01:20 | approved for the treatment of needy in two thousand and five |
---|
0:01:25 | it's far marco kinetic profiles included t max of zero point eight to one point |
---|
0:01:31 | three hours |
---|
0:01:33 | and see how |
---|
0:01:34 | that's nine point nine to twelve point one hours |
---|
0:01:38 | which could convert clinical properties of both relative rapid onset and long duration of ash |
---|
0:01:47 | compared with the syllable |
---|
0:01:48 | you jennifer significantly improves the direct i'll function domain scores of i |
---|
0:01:56 | the rates of successful penetration and maintenance of ration in and with the d but |
---|
0:02:02 | broad spectrum of you q all the keys |
---|
0:02:05 | forces there |
---|
0:02:07 | also you dental treatment showed greater increases in positive responses to the global assessment question |
---|
0:02:14 | compared to placebo |
---|
0:02:19 | also you gender phyllis save effective and well tolerated for the treatment of e d |
---|
0:02:25 | in men with underlying hypertension who take an entire hyper tense address |
---|
0:02:33 | there is evidence that you gotta fill can be as effective in the treatment of |
---|
0:02:38 | diabetes melody is associated e d as other pde five inhibitors |
---|
0:02:45 | due to the clinical properties you jennifer can be another option of deal with those |
---|
0:02:50 | in for the treatment of d as suggested by favourable efficacy and safety profile |
---|
0:02:58 | cover administration of one hundred milligram you'd n f l and out for one blockers |
---|
0:03:03 | improve dirac function and lower urinary tract symptoms impatience with both bp h and e |
---|
0:03:11 | d |
---|
0:03:12 | also the common commitment use of our focus on bloggers does not significantly affect the |
---|
0:03:19 | c d profile of you jennifer |
---|
0:03:23 | most adverse effect reporter by clinical trials are mild or moderate in so there without |
---|
0:03:30 | any serious adverse event with had a and flashing being the most common |
---|
0:03:38 | to date there have been no data on long-term efficacy and holler ability you'd n |
---|
0:03:43 | f l for the treatment you d |
---|
0:03:46 | also there has to sparse data on efficacy and safety you data feel for the |
---|
0:03:51 | treatment of e d in other ethnic populations and east asian population |
---|
0:03:58 | that's research on e d treatment using you don't know that is still ongoing |
---|
0:04:05 | in conclusion you data that has fruit and have high efficacy of favourable safety profile |
---|
0:04:10 | for the broad spectrum you d patients which are compared to those other pde five |
---|
0:04:17 | inhibitors |
---|
0:04:18 | due to the clinical properties of relatively rapid onset and long duration of action you'd |
---|
0:04:25 | and the main be a better option for d treatment according to patient specific sexual |
---|
0:04:31 | and harass |
---|
0:04:33 | you don't have l is as effective in the treatment of diaries mallets is associated |
---|
0:04:39 | e d as a pde five and hitters |
---|
0:04:44 | further studies are still required to validate the efficacy and safety you jennifer |
---|
0:04:49 | and to complement the scientific basis rationale evidence this prescription and dosing decision |
---|
0:04:56 | thank you for your attention |
---|